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Tick-borne encephalitis virus (TBEV) causes 13,000 cases of human meningitis and ence-
phalitis annually. However, the structure of the TBEV virion and its interactions with anti-
bodies are unknown. Here, we present cryo-EM structures of the native TBEV virion and its
complex with Fab fragments of neutralizing antibody 19/1786. Flavivirus genome delivery
depends on membrane fusion that is triggered at low pH. The virion structure indicates that
the repulsive interactions of histidine side chains, which become protonated at low pH, may
contribute to the disruption of heterotetramers of the TBEV envelope and membrane proteins
and induce detachment of the envelope protein ectodomains from the virus membrane. The
Fab fragments bind to 120 out of the 180 envelope glycoproteins of the TBEV virion. Unlike
most of the previously studied flavivirus-neutralizing antibodies, the Fab fragments do not
lock the E-proteins in the native-like arrangement, but interfere with the process of virus-
induced membrane fusion.
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T ick-borne encephalitis virus (TBEV) infects a range ofhosts including ruminants, birds, rodents, and carnivoresthat provide a reservoir from which the virus can be
transmitted to humans1. Annually, Europe and Russia report
10,000–13,000 cases of TBEV-induced meningitis, encephalitis, or
meningoencephalitis2,3. Mortality varies depending on the TBEV
subtype. Whereas in Europe it is usually between 1 and 2%, with
deaths occurring 5–7 days after the onset of the neurological
symptoms1, far-eastern TBEV causes more severe diseases with
mortality in the range of 5–20%2. Long-lasting or permanent
neuropsychiatric disorders are observed in 10–20% of infected
patients3.
Vaccines are an effective means of protection against flavivirus-
caused diseases, including TBEV4; however, not all people in the
TBEV-affected areas are vaccinated, and the numbers of annual
infections are increasing2. Therefore, therapeutic tools against
TBEV are required. One possible treatment is the infusion of
neutralizing antibodies, which has been shown to confer protec-
tion against infection by several flaviviruses, including TBEV5.
TBEV belongs to the family Flaviviridae of positive-sense,
single-stranded RNA viruses. Mature flavivirus virions are
membrane-enveloped with a diameter of 50 nm6–8. Attachment
of the virus particles to cells is receptor-mediated, and the
infection is initiated after the uptake of virions into endo-
somes9,10. Low pH in the endosomes initiates conformational
changes of virus envelope glycoproteins that induce fusion of the
virion membrane with the membrane of the endosome11,12. After
delivery into the cytoplasm, the ~10,000-nucleotide-long positive-
sense single-stranded RNA genome is translated into polyproteins
that are co-translationally and post-translationally cleaved into
functional subunits, which include protease, RNA-dependent
RNA polymerase, capsid, and envelope proteins. Virus envelope
(E) and pre-membrane (prM) proteins are co-translationally
inserted into the membrane of the endoplasmatic reticulum. The
replication of flaviviruses occurs in the cytoplasm, in close asso-
ciation with membranes, in the so-called virus replication fac-
tories13. Immature flavivirus virions are formed by budding of the
complex of the genome with capsid proteins into the lumen of the
endoplasmatic reticulum. The surface of the immature particles is
covered with trimers of prM–E protein heterodimers14–16. The
newly formed virions encounter acidic pH as they are transported
into the Golgi complex and trans-Golgi network. The low pH
induces reorganization of E-proteins into a herringbone-like
arrangement14, which starts from a nucleation center and then
spreads around the particle17,18. Immature virions contain intact
prM peptides that cover the fusion loops of the E-proteins and
thus prevent fusion of the virus with intracellular membranes19.
After the low-pH-induced reorganization of the envelope glyco-
proteins, a cleavage site for the protease furin within the prM
peptide becomes exposed at the virion surface, and the peptide is
cut into pr and M-fragments14,20. When the virions are released
from cells into the extracellular space with neutral pH, the pr-
peptides dissociate from the particles, rendering the virions
mature and fusion-competent14,21. The structures of mature
virions of the dengue (DENV), Zika (ZIKV), West Nile (WNV),
and Japanese encephalitis viruses (JEV) and of the sub-viral
particle of TBEV were solved previously by cryo-EM6,7,22–24. The
structures of E-protein ectodomains of TBEV and other flavi-
viruses were determined in the form of dimers and post-fusion
trimers25–28.
Here, we report the structures of the native TBEV virion and its
complex with the Fab fragments of the neutralizing antibody 19/
1786. Our results indicate that the low-pH-induced protonation
of histidines may contribute to disruption of the E–M hetero-
tetramers and induce detachment of the E-protein ectodomains
from the virus membrane. Furthermore, the binding of 19/1786
antibodies to the TBEV surface does not prevent the low-pH-
induced movements of E-proteins; however, it does interfere with
the virus-induced membrane fusion.
Results and discussion
Structure of TBEV virion. Cryo-electron micrographs of purified
TBEV virions showed smooth spherical particles with a diameter
of 50 nm, similar to those of other flaviviruses (Fig. 1a)6,8,23.
Many TBEV particles were irregular or damaged and therefore
could not be used for cryo-EM reconstruction with icosahedral
symmetry (Fig. 1a). Nevertheless, the structure of the mature
TBEV particle was determined to a resolution of 3.9 Å (Fig. 1b,
Supplementary Fig. 1a, b, c, Table 1). The quality of the map was
sufficient to enable the building of the protein components of the
TBEV envelope, which contains three E-proteins and three M-
proteins in each icosahedral asymmetric unit. The surface of the
TBEV virion is covered with small protrusions formed by glycans
attached to the E-protein subunits (Fig. 2a). Two E-proteins and
two M-proteins form a compact heterotetramer (Fig. 2b). Three
of these heterotetramers constitute the so-called herringbone
pattern characteristic of the envelopes of flaviviruses (Supple-
mentary Fig. 1d)6,23,29,30. In contrast to the principles suggested
by Caspar and Klug and unlike most isometric viruses, the three








Fig. 1 Structure of TBEV virion. a Cryo-EM image of TBEV virions. The
sample contained mature, immature (white arrows), half-mature (white
arrowheads), and damaged (black arrows) particles. Scale bar 100 nm. b B-
factor sharpened electron-density map of TBEV virion, rainbow-colored
according to distance from particle center. The front lower-right eighth of
the particle was removed to show the transmembrane helices of E-proteins
and M-proteins. cMolecular surface of TBEV virion low-pass filtered to 7 Å.
The three E-protein subunits within each icosahedral asymmetric unit are
shown in red, green, and blue. The three E-proteins in the icosahedral
asymmetric unit form unique interactions with each other (for more details,
see Supplementary Fig. 2). The black triangle shows the borders of a
selected icosahedral asymmetric unit. d Central slice of TBEV electron
density map perpendicular to the virus 5-fold axis. The virus membrane is
deformed by the transmembrane helices of E-proteins and M-proteins. The
lower right quadrant of the slice is color-coded as follows: nucleocapsid—
blue; inner and outer membrane leaflets—orange; M-proteins—red; E-
proteins—green. Scale bars in b, c, and d represent 10 nm
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unique interactions with the surrounding glycoproteins (Fig. 1c,
Supplementary Fig. 2)6–8. Both E-proteins and M-proteins are
anchored in the virion membrane, each by two trans-membrane
helices (Fig. 2c, d). The inner and outer leaflets of the membrane
are clearly separated in the cryo-EM map (Fig. 1d). However,
individual lipids are not resolved in the reconstruction because of
the fluidic character of the membrane. The shape of the virus
membrane is not spherical; instead it closely follows the inner
surface of the protein envelope. The membrane is deformed by
insertions of the trans-membrane helices of E-proteins and M-
proteins (Fig. 1d). Similar shapes of virion membranes were
previously observed in DENV, ZIKV, and WNV7,8,23. Inside the
envelope is a nucleocapsid core that is not ordered with icosa-
hedral symmetry; therefore, the corresponding regions of the
electron density map do not contain any resolved features
(Fig. 1d, Supplementary Fig. 1c).
Organization and structure of TBEV E-proteins. The structures
of TBEV E-proteins could be built for residues 1–492 out of 496.
The E-protein is, according to the flavivirus convention, divided
into four domains27. The three N-terminal domains are mostly
composed of β-strands and form an ectodomain that covers the
virion surface (Fig. 2c). Domain I, which has a β-barrel fold,
constitutes the center of the ectodomain between the domains II
and III (Fig. 2c). Domain I includes the only glycosylation site of
TBEV at Asn154 (Fig. 2a). The cryo-EM reconstruction contains
densities corresponding to N-acetyl-D-glucosamine in all three
E-protein subunits of the asymmetric unit. The E-proteins of the
majority of TBEV, WNV, ZIKV, and JEV strains contain a single
homologous glycosylation site, whereas that of DENV has an
additional glycosylation site at Asn678. It was shown that the
glycosylation of the TBEV E-protein is important for the secre-
tion of the virus from infected cells31.
The domain IIs of two E-proteins, which form a dimer in the
native TBEV virion, are in contact through an interface with a
buried surface area of 1490 Å2. The domain II contains a fusion
loop formed by residues 100–109 with hydrophobic side chains.
The loop is positioned at the tip of the ectodomain (Fig. 2a). It is
essential for fusion of the virus membrane with that of an
endosome, which enables delivery of the virus genome into the
cytoplasm of a host cell. In mature TBEV, the loop is covered in a
pocket formed by domains I and III of the other E-protein from
the same dimer (Fig. 2a, Supplementary Fig. 3).
Domain III of TBEV E-protein has an immunoglobulin-like
fold (Fig. 2c). Antibodies targeting domain III are more likely to
neutralize the virus than those interacting with other parts of the
ectodomain32. There is evidence that neutralizing antibodies
binding to domain III prevent pH-induced conformational
changes of E-proteins, which are required for membrane fusion,
or sterically block receptor binding27,33.
The structures of E-protein ectodomains within the TBEV
virion and of the isolated E-domain solved previously by X-ray
crystallography27 have an root-mean-square deviation (RMSD) of
Table1 Cryo-EM data collection, refinement, and validation statistics




TBEV-Fab 19/1786, pH 5.8 (EMD-
3755)
Data collection and processing
Magnification 75,000× 75,000× 75,000×
Voltage (kV) 300 300 300
Electron exposure (e–/Å2) 22 22 22
Defocus range (μm) 0.8–3.8 0.8–3.7 0.8–3.4
Pixel size (Å) 1.063 1.063 1.063
Symmetry imposed Icosahedral Icosahedral Icosahedral
Initial particle images (no.) 19,111 12,098 4515
Final particle images (no.) 11,882 5929 3831
Map resolution (Å) 3.9 3.9 19.2
FSC threshold 0.143 0.143 0.143
Map resolution range (Å) 3.8–6.2 3.8–7 19.2
Refinement
Initial model used (PDB code) 1SVB, 3J27 1SVB, 3J27 –
Model resolution (Å) 3.9 3.9 –
FSC threshold 0.143 0.143 –
Model resolution range (Å) ∞−3.9 ∞–3.9 –
Map sharpening B-factor (Å2) −115 −104 0
Model composition –
Non-hydrogen atoms 12,942 19,346 –
Protein residues 1689 2529 –
Ligands 3 3 –
B-factors (Å2) –
Protein 116.2 154.1 –
Ligand 126.3 88.4 –
R.m.s. deviations –
Bond lengths (Å) 0.006 0.007 –
Bond angles (°) 1.06 1.15 –
Validation –
MolProbity score (percentile) 1.59 (100) 1.66 (100) –
Clashscore (percentile) 2.62 (100) 3.27 (100) –
Poor rotamers (%) 0.0 0.47 –
Ramachandran plot –
Favored (%) 90.34 90.16 –
Allowed (%) 9.36 9.44 –
Disallowed (%) 0.30 0.40 –
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1.7 Å for the corresponding Cα atoms. The most important
difference is in the positioning of domains I–III relative to each
other. Whereas in the crystal structure the domains I, II, and III
are arranged in a line, in the virion the tip of domain II is bent 15
Å toward the virus membrane (Fig. 2c). A similar hinge-like
movement of the domain II was described previously for E-
proteins of WNV and DENV8,28,34. The bending of the
ectodomain in the virion is necessary to keep the fusion loop
buried in the hydrophobic pocket of the other E-protein from the
same dimer, so that the loop is prevented from untimely
induction of membrane fusion.
The C-terminal domain IV anchors the E-protein in the virus
membrane. Domain IV is composed of five helices (Fig. 2c). The
three N-terminal helices are perimembrane, whereas the last two
are transmembrane. The perimembrane helices located in the
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transmembrane helices are mostly hydrophobic. In the cryo-EM
reconstruction of the TBEV virion, the domains IV are less well
resolved than the ectodomains (Fig. 1d, Supplementary Fig. 1c).
The virus membranes are acquired during budding, and are likely
to be variable in lipid composition and to some extent also in the
number of lipid molecules that are present in each virion. The
variations in the virus membranes are likely to affect the
positioning of E-protein helices in particular virions. Therefore,
averaging the images of many particles during the process of
three-dimensional reconstruction results in a smearing of details
of the helices interacting with the membrane. In contrast, the
ectodomains are tightly packed on the virus surface and their
relative movements are limited.
Structure of the M-protein. Due to its small size and association
with the virus membrane, the M-protein is not exposed at the
virion surface. Residues 2–72 out of 75 of the M-protein could be
built in the cryo-EM electron density map of TBEV. The M-
protein consists of an N-terminal loop and three helices (Fig. 2d).
The first helix is perimembrane and the last two are
transmembrane.
Two M-proteins and two E-proteins form a heterotetramer in
which each M-protein interacts with both E-proteins (Fig. 2b,
Supplementary Fig. 4). This complex is the basic building block of
the mature virion. The N-terminal loop of the M-protein interacts
with domain II of the E-protein and presumably prevents the
reorganization of E-protein dimers into fusogenic trimers8. The
membrane part of the same M-protein interacts with the
transmembrane domain of the other E-protein from the same
heterotetramer, thus stabilizing the E-protein dimer (Fig. 2b,
Supplementary Fig. 4).
Role of histidines in putative pH sensing mechanism. Flavi-
viruses deliver their genomes into the cell cytoplasm by fusing the
virus and endosome membranes35. This fusion is induced by
trimers of E-proteins that form when the virions are exposed to
low pH in the endosomes11,33. The environment in endosomes
with pH lower than 5.8 can cause protonation of side chains of
histidines, which become positively charged. It was proposed that
in the dengue virus, the protonated His7 from the M-protein and
His208 from the E-protein repel each other and induce the dis-
ruption of E–M heterodimers8. The E-proteins can then form
trimers and induce membrane fusion8. TBEV homologs His7 and
His216 are located 5.9 Å away from each other (Fig. 2e), and are
therefore likely to have the same function in sensing low pH.
Additionally, His17 of the TBEV M-protein and His248 of the E-
protein are separated by 5.7 Å, and after protonation might also
contribute to heterodimer destabilization (Fig. 2e). His7 of the M-
protein is conserved among many flaviviruses, whereas His17 is
only conserved among tick-borne flaviviruses (Fig. 2f, Supple-
mentary Fig. 5), indicating that there might be a unique
mechanism of structure destabilization for this group of viruses.
Furthermore, His287 and His419 of the TBEV E-protein are
located 4.3 Å from each other and may electrostatically repel each
other when protonated at low pH (Fig. 2e). His287 is part of
domain I, whereas His419 belongs to the second perimembrane
helix of the E-protein (Fig. 2c, e). Repulsion between these amino
acids is likely to trigger the release of ectodomains of E-proteins
from the virus envelope, enabling the formation of fusion trimers.
Homologs of His287 and His419 of TBEV are present in several
other flaviviruses, and the mechanism for inducing detachment of
the E-protein ectodomain from the virus membrane might be
shared within the virus family (Fig. 2f, Supplementary Fig. 5).
Four out of the six histidines that interact with each other within
the TBEV heterotetramer have pKa values equal to or higher than
5.8 (Fig. 2g). This provides additional evidence that the histidines
could serve as pH sensors. These pKa calculations are sensitive to
the precise locations of amino-acid side chains within the protein
structure36. It is therefore important that the role of histidines in
controlling the pH-mediated conformational switch of the flavi-
virus E-proteins is supported by previous experimental evidence.
Nelson et al. demonstrated that WNV E-proteins with single
mutations in histidines do not differ from the wild-type virus in
their capacity to induce membrane fusion37. Similarly, Fritz et al.
showed that single mutants of TBEV E-protein His248Asn and
His287Ala could induce membrane fusion with an efficiency
similar to that of the wild-type38. However, the double mutant
His248Asn and His287Ala had a lower efficiency of formation of
E-protein trimers, and its sub-viral particles were nearly fusion
incompetent. In combination, the mutational and structural
analyses provide evidence that the disruption of E–M hetero-
dimers and detachment of the E-protein ectodomains from the
virion membrane may depend on the protonation of histidines in
the low pH of late endosomes.
Patches of the heterotetramer surface became positively
charged at pH 5.8, which approximates that of the late endosomes
(Fig. 2g). The alteration of the surface charge distribution may
further contribute to the initiation of the conformational changes
required for the formation of pre-fusion E-protein trimers.
Structure of TBEV virion covered with Fab 19/1786. Mouse
monoclonal antibody IgG1 19/1786 has therapeutic potential
because it neutralizes multiple strains of TBEV and has minimal
cross-reactivity with other flaviviruses39. We determined the EC50
values for the whole antibody and Fab fragment to be 0.24± 0.03
and 35.0± 2.5 µg ml−1, respectively (Fig. 3a, b). It is common that
the inhibiting concentration of Fab is more than 100 times higher
than that of the full antibody40. After the incubation of TBEV
Fig. 2 Structure and organization of the E-proteins and M-proteins in TBEV virion. a Dimer of E-proteins with domain I colored in red, domain II in yellow,
domain III in violet, and domain IV in blue. The electron density map of one of the proteins is shown as a semi-transparent surface. Glycosylation site
Asn157 and residues Trp101 and Phe108 from the fusion loop of domain II are shown in detail. b Heterotetramer of two E-proteins and two M-proteins.
E-proteins are colored according to domains, and M-proteins are shown in orange. c Superposition of cryo-EM (colored) and X-ray (gray) E-protein
structures27. The cryo-EM structure includes three perimembrane (h1–h3) and two transmembrane helices (h4 and h5). dM-protein rainbow-colored from
N-terminus in blue to C-terminus in red with electron density map shown as semi-transparent surface. The M-protein consists of an extended N-terminal
loop followed by perimembrane (h1) and two transmembrane helices (h2 and h3). e Molecular surface of E–M heterotetramer. Histidines with a putative
role in the dissociation of the heterotetramers are shown in magenta. Insets show details of interactions of the histidine side chains. f Structures of
E-proteins and M-proteins colored according to conservation of amino acid sequence among viruses from the family Flaviviridae (for more details, see
Supplementary Fig. 5). Insets show the conservation of histidines that might be involved in the pH-dependent dissociation of the heterotetramers. g
Molecular surface of E–M heterotetramer colored according to electrostatic potential at pH 8.5 and 5.8. One E–M heterodimer is shaded for clarity. Insets
show the surface potential surrounding the histidines that might be involved in the pH-dependent dissociation of the hetrotetramer. The table in the middle
lists the pKa values of the selected histidines calculated using Rosetta-pKa36
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with Fab fragments of 19/1786 the virions became “spiky” in
appearance, confirming that the Fab fragments had attached to
the virus (Fig. 4a). Cryo-EM reconstruction of the TBEV–Fab
complex was determined to a resolution of 3.9 Å (Fig. 4b, Sup-
plementary Fig. 6, Table 1). Two Fab fragments attached to each
icosahedral asymmetric unit of the TBEV virion (Fig. 4b, c, d).
The binding of the Fab fragments did not induce any major
changes in the virion structure. The electron density map of the
Fab fragments enabled the building of the structure of the variable
loops of the antibodies that are responsible for virus recognition
(Supplementary Figs. 7, 8). The constant parts of the Fab frag-
ments distant from the virus surface were less well resolved,
indicating the flexibility of the complex (Fig. 4b, Supplementary
Fig. 6b).
Because of the non-quasi-equivalent organization of the TBEV
particle, the two Fab fragments bound within one asymmetric
unit differ in some interactions with the E-proteins. One of the
Fab fragments binds next to the icosahedral 3-fold axis of the
TBEV envelope (Fig. 4d). The Fab interacts with domain III of
one E-protein and domain I of the E-protein from a neighboring
asymmetric unit (Fig. 4d, Supplementary Fig. 7). The other Fab
fragment binds close to the icosahedral 5-fold axis to domain III
and interacts with domain II of an E-protein from a neighboring
asymmetric unit (Fig. 4d, Supplementary Fig. 8). The Fab 19/1786
could not bind to the third E-protein within the icosahedral
asymmetric unit because upon binding to domain III of the
unoccupied E-protein, the heavy chain of the Fab would clash
with domain III of a neighboring E-protein (Supplementary
Fig. 9). Therefore, each TBEV virion can bind up to 120 Fab
fragments of antibody 19/1786. All the Fab attachment sites can
be occupied by complete antibodies of type G without steric
hindrance (Supplementary Fig. 10). It is notable that antibodies
E16 and ZV-54/ZV-67, which can neutralize WNV41 and
ZIKV42, respectively, also interact with the domain IIIs of E-
proteins and bind to the virus particles with the same
stoichiometry as that of 19/1786. The Fab fragments of antibody
19/1786 were mixed with the virus in an equimolar ratio relative
to E-proteins. However, the electron density map of the complex
had lower-density values in the regions corresponding to Fab
than in the regions of the viral envelope. This indicates that the
Fab fragments did not have full occupancy. Using a localized 3D
classification technique43, the occupancy of the Fab fragment
bound close to the 3-fold icosahedral axis was determined to be
70%, whereas that of the fragment bound close to the 5-fold axis
was 60%.
The major interaction site of the 19/1786 Fab fragment with
the virus is the domain III of the E-protein. The 19/1786 Fab
fragments bind to this site at an angle of 135° from the virus
surface (Fig. 4e). The same amino acids of hypervariable regions
of heavy and light chains of the antibody are in contact with the
amino acids of the domain III at both of the attachment sites
within the icosahedral asymmetric unit. The total buried surface
area of the interface is 730 Å2. The interaction is formed mainly
via salt bridges and hydrogen bonds. Part of the heavy chain of
the Fab bound close to the 3-fold axis interacts with domain I of
the E-protein through an interface with a buried surface area of
300 Å2 (Supplementary Fig. 7). Part of the Fab heavy chain
interacts with the domain II close to the 5-fold axis through a
buried surface area of 370 Å2 (Supplementary Fig. 8). One of the
E-proteins from the icosahedral asymmetric unit interacts with
three Fabs, the second E-protein with one Fab and the third E-
protein does not interact with any (Fig. 4d).
It was shown previously that the replacement of Thr310 in the
TBEV E-protein with another amino acid resulted in a decreased
infectivity of the mutant virus44. It was speculated that this
residue is important for receptor recognition44. Thr310 is part of
the 19/1786 binding site (Supplementary Figs. 7, 8). It is therefore
possible that the interaction of antibody 19/1786 with domain III
may interfere with the binding of TBEV to its putative receptor.
To determine whether the interaction of antibody 19/1786 with
domains I and II had any role in the virus neutralization, we
prepared viruses with mutations in the antibody binding sites. In
domain I two amino acids that form hydrogen bonds with the
heavy chain of the antibody (Supplementary Fig. 7) were mutated
to amino acids with opposite charges (double mutant Glu51Gln
and Lys161Asn). To further disrupt the interaction interface, a
quadruple mutant was prepared in which two additional amino
acids with small side chains were replaced with tyrosine
(Glu51Gln, Lys161Asn, Ser158Tyr, and Thr279Tyr). In order to
disrupt the binding site of the antibody in domain II, two and
four amino acids were replaced with residues with opposite
charges (double mutant Asp67Asn, Lys69Glu and quadruple
mutant Asp67Asn, Lys69Glu, Glu84Gln, and Gln87Glu). The
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Fig. 3 Neutralization of TBEV by antibody 19/1786. Dose-dependent neutralization curves of TBEV treated with IgG 19/1786 (a) and Fab 19/1786 (b). Error
bars represent standard deviation of the measurements (IgG n= 5; Fab n= 2). EC50 values with standard error of the mean are shown in the graph. c Dose-
dependent neutralization curves of TBEV and its mutants treated with IgG 19/1786. Mutations in domain I (red circle—double mutant; blue triangle—
quadruple mutant) and domain II (magenta triangle—double mutant; green diamond—quadruple mutant) affect the neutralization activity of Fab 19/1786
compared to the wild-type virus (black square). The mutations in the domains are listed in the top left corner. The error bars represent the standard
deviation of the measurements (n= 3). Calculated EC50 values (µg ml−1) with standard errors are listed in the bottom right corner
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antibody 19/1786 neutralization, with EC50 values increasing
from 0.16 μg ml−1 for the wild-type virus to 0.77 μg ml−1 and 0.49
μg ml−1 for the double and quadruple mutants, respectively
(p-values< 0.0001; Fig. 3c). The quadruple mutant exhibited
lower resistance to the neutralization than the double mutant
(p = 0.0068). Presumably the additional mutations in its domain I
served as suppressor mutations instead of having the expected
synergic effect. A less pronounced reduction in the neutralization
activity was observed for the mutants of domain II, with EC50
values increasing to 0.30 and 0.29 μg ml−1 for the double and
quadruple mutants, respectively (p-values ≤ 0.0086, Fig. 3c). The
difference in the EC50 values of the two mutants in domain II is
not statistically significant (p = 0.835). The results of these
mutational experiments indicate that the interaction of antibody
19/1786 with domains I and II contributes to virus neutralization.
The binding of the antibody to domain II may prevent the
induction of membrane fusion, whereas the interaction with
domain I may interfere with the hinge movement that is required
for the formation of pre-fusion trimers8. Nevertheless, the
interactions of antibody 19/1786 with domains I and II appear
to be only auxiliary, and the function of the antibody probably
depends mostly on its interaction with domain III.
Fab 19/1786 may prevent TBEV membrane fusion. Flaviviruses
enter their host cells by receptor-mediated endocytosis45. The low
pH in endosomes triggers a conformational rearrangement of the
E-proteins that involves the formation of a cone-shaped trimer
from E-protein ectodomains, which has fusion loops exposed at
its tip46. The fusion loops interact with the endosome and trigger
fusion of the endosome and virus membranes, resulting in the
subsequent release of the virus nucleocapsid core into the cell
cytoplasm10,47.
Purified flavivirus particles exposed to a low-pH solution
in vitro fuse with each other (Fig. 5a)48. The binding of Fab
fragments of antibody 19/1786 prevented the fusion of TBEV
virions at pH 5.8 (Fig. 5a). However, this might be caused by the
inaccessibility of the virus membrane at the surface of the Fab-
decorated TBEV virions. To determine whether IgG 19/1786 and
Fab 19/1786 can prevent membrane fusion in vivo, we performed
a “fusion-from-without” assay using C6/36 cells49. Whereas the
native TBEV induces cell fusion at low pH, the virus in complex
with IgG 19/1786 lost this ability, and the virus in complex with
the Fab 19/1786 induced cell fusion with lower efficiency than the
native virus (Fig. 5b). The incomplete inhibition of the fusion by
the Fab fragments is in agreement with the results of the
neutralization test, which show that the EC50 value of the Fab is
150× higher than that of the full IgG (Fig. 3a, b).
Cryo-EM reconstruction of the TBEV–Fab complex at low pH
with imposed icosahedral symmetry produced maps with a
resolution limited to 19.2 Å, indicating that the particles are
pleiomorphous (Fig. 5c, Supplementary Fig. 6a). The low-







Fig. 4 Interaction of TBEV virions with Fab fragments of neutralizing antibody 19/1786. a Cryo-EM micrograph of TBEV virions incubated with Fab
fragments of 19/1786. Scale bar represents 100 nm. b Electron-density map of Fab-covered TBEV virion rainbow-colored according to distance from center
of particle. The right half of the image represents a B-factor sharpened map. Electron densities corresponding to the Fab fragments are located close to the
3-fold and 5-fold symmetry axes of the virion. c Molecular surface of TBEV virion covered with Fab 19/1786 fragments low-pass filtered to 7 Å resolution.
E-proteins are shown in red, green, and blue. Fab fragments are shown in magenta (heavy chain) and pink (light chain). Scale bars in b and c represent 10
nm. d Footprints of Fab 19/1786 on TBEV surface. Fab fragments bind to two of the E-proteins of the asymmetric unit. The Fabs interact with an additional
E-protein from the neighboring asymmetric unit shown in faint colors. e The Fab 19/1786 binds to the domain III at an angle of 135° relative to the axis of
the E-protein ectodomain. The E-protein domain I is shown in red, domain II in yellow, domain III in violet, and domain IV in blue. The heavy chain of the Fab
fragment is shown in magenta and the light chain in pink. The leaflets of the viral membrane are represented by gray dashed lines
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organization of the E-protein ectodomains (Fig. 5c). This is
corroborated by 2D class-averages of the virions (Fig. 5d).
Particles with bound Fab fragments at low pH lack the density
corresponding to the ectodomain layer, whereas the lipid bilayer
enclosing the nucleocapsid core is intact (Fig. 5c, d). Notably, the
leaflets of the lipid layer are spherical and have lost the
deformations present in the native particles (Fig. 5c, d). This
indicates a reorganization of the positions of transmembrane
helices of the E-proteins and M-proteins. Most likely the proteins
lost their icosahedral ordering and became irregularly distributed
in the virus membrane. Even though the ectodomains of E-
proteins detached from the virus membrane, the fusion capability
of the virus became impaired because of the Fab binding. Chao
et al. had shown that availability of competent monomers within
the contact zone between virus and target membrane makes
trimerization a bottleneck in hemifusion11. It is therefore possible
that the Fab 19/1786 binding interferes with the conformational
rearrangement of the E-protein dimers into fusogenic trimers.




TBEV, pH 8.5 TBEV + Fab, pH 8.5
TBEV + Fab, pH 5.8
TBEV, pH 8.5 TBEV + Fab 1786, pH 8.5
TBEV + Fab 1786, pH 5.8
d
C6/36+TBEV + Fab 1786, pH 5.5
C6/36, pH 5.5 C6/36+TBEV, pH 5.5
C6/36+TBEV + IgG 1786, pH 5.5
Fig. 5 TBEV virions and TBEV–Fab 19/1786 complex in low-pH environment. a Cryo-EM micrographs of TBEV virions fused together under low-pH
conditions. However, TBEV virions covered with Fab 19/1786 fragments did not aggregate. Scale bar represents 100 nm. b “Fusion-from-without” assay on
C6/36 cells. The control cells did not fuse in the low-pH (5.5) environment. In contrast, native TBEV induced complete cell fusion. Pre-incubation of TBEV
with IgG 19/1786 completely abolished the fusion activity of the virus and the Fab 19/1786 lowered the fusion activity of the TBEV. The scale bar
represents 100 µm. c Cryo-EM reconstruction of Fab-covered TBEV virion at low pH. The isosurface is radially colored according to the distance from the
center. Corresponding central slice perpendicular to the 5-fold axis is shown on the right. The particles lost the compact layer of the E-protein ectodomain
and the viral membrane is not deformed by the transmembrane helices. The lower right quadrant of the slice is color-coded as follows: nucleocapsid—blue;
inner and outer membrane leaflets—orange; M-proteins, E-proteins, and Fab fragments cannot be distinguished and are shown in green. The scale bar
represents 25 nm. d Reference-free 2D class averages of TBEV virions in solutions with different pH levels. The upper half of the images shows the class
averages, whereas the bottom parts are radial averages of the same classes. In the radial averages, the three distinct layers represent the inner and outer
leaflets of the membrane (in orange) and the ectodomain of the E-proteins (in green). An additional double layer is visible on the virion covered with Fab
fragments (in cyan). The layer corresponding to ectodomains of E-proteins and Fab fragments is more diffuse in the low-pH structure than in the particles
at neutral pH. The viral membrane remained fully preserved, but lost the deformities introduced by the transmembrane helices of virus proteins. The 2D
class averages are color-coded as follows: nucleocapsid—blue; inner and outer membrane leaflets—orange; E-proteins—green; Fab 19/1786 attached to
virus surface—cyan. The scale bar represents 25 nm
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The mechanisms of virus neutralization differ depending on
the virus and the neutralizing antibody. Zika virus covered with
Fab fragments of the C10 antibody exhibited extraordinary
stability at low pH because the ectodomains of the E-proteins
were locked in dimers similar to those in the native virus50. The
crystal structure of a human antibody which is active against all
DENV serotypes in complex with the E-protein ectodomain
revealed an “E-dimer-dependent epitope” that includes the
conserved main chain of the fusion loop and the two conserved
glycosylation sites of the virus51. The Fab fragment of antibody
5J7 bound across all three E-proteins of one icosahedral
asymmetric unit of DENV3 and neutralized the virus by a
combination of locking the ectodomains in place and steric
obstruction of the receptor binding30. Steric hindrance of the
conformational rearrangement of E-proteins is also the proposed
neutralization pathway of the E16 Fab complex with WNV52. A
neutralization mechanism similar to that of Fab 19/1786 was
observed for DV2-E104 Fab. The Fab fragments did not lock the
DENV2 E-protein in dimers; however, they inhibited the
membrane fusion process53. Because the IgG 19/1786 antibody
is not cross-reactive against other flaviviruses and efficiently
neutralizes TBEV39, it has potential for therapeutic use.
Methods
Production and isolation of mature TBEV particle. Purified TBEV virions were
prepared using a modified protocol for the dengue virus6. Human neuroblastoma
cells UKF-NB4 were grown to 100% confluence in IMDM medium supplemented
with 10% FBS at 37 °C in the presence of 5% CO2 in 30 flasks, each with a bottom
surface area of 300 cm2. The cells were infected with the TBEV strain Hypr (low-
passage TBEV strain isolated in 1953 from the blood of a deceased child with TBE)
at an MOI of 0.5. After 5 h of incubation at 37 °C, the medium was replaced with
fresh medium without FBS. The culture media were harvested 35 h post infection
and clarified by centrifugation at 5700 × g for 10 min at 4 °C. The supernatant was
precipitated by adding PEG 8000 to a final concentration of 8% (w/v) and incu-
bating overnight at 4 °C with mild shaking. After that, the virus was pelleted by
centrifugation at 10,500 × g for 50 min at 4 °C. The resulting pellet was resuspended
in 2 ml of NTE buffer (20 mM Tris, 120 mM NaCl, 1 mM EDTA, pH 8.5). The
solution was clarified by centrifugation at 1500 × g for 5 min at 4 °C. RNAse was
added to the supernatant to a final concentration of 10 μg ml−1 and incubated for
15 min at 10 °C. The solution was loaded onto a step tartrate gradient (10, 15, 20,
25, 30, and 35%) in NTE buffer. After separation in a Himac CP80WX ultra-
centrifuge (Hitachi) with a P40ST swinging bucket rotor at 32,000 rpm for 2 h at 4 °
C, a visible band containing the virus was harvested using a syringe with a needle.
Finally, the collected virus was repeatedly diluted with 4 ml of NTE buffer and
concentrated to a final volume of 100 µl using a centrifugal filter concentrator with
a 100-kDa cut off (Vivaspin® 6 Centrifugal Concentrator, Vivaproducts).
Virus neutralization assay. Virus neutralization by the 19/1786 mAb and corre-
sponding Fab fragments was measured according to a previously published pro-
tocol39. Briefly, serial dilutions of the antibody and Fab fragment were prepared,
mixed with TBEV (1000 PFUml−1), and incubated at 37 °C for 2 h. After the
incubation, the mixtures were applied to monolayers of porcine kidney stable cells
in 96-well plates, and incubated for 4 days at 37 °C. The cytolysis was examined
using light microscopy and the neutralization rate was determined. The assay was
done in triplicates for the IgG and in duplicates for the Fab. Neutralization curves
were constructed from the measured data and EC50 values with corresponding
standard errors were calculated from the fitted Hill dose-response curve.
C6/36 cell fusion assay. A fusion-from-without assay was performed as described
previously49. Mosquito C6/36 cells were grown in 96-well tissue cell culture plates
for 2 days. The cells were precooled for 45 min at 4 °C, then washed with serum-
free medium. Cells were incubated for 1 h at 4 °C with 30 µl of purified virus at a
concentration of 500 µg ml−1 or a mixture of virus pre-incubated (30 min) with IgG
19/1786 (100 µg ml−1) or Fab 19/1786 (3000 µg ml−1). After removal of the virus
suspension, pre-warmed fusion medium (MEM buffered with 20 mM MES, pH
5.5) was added to the cells and the plates were incubated for 2 min at 40 °C. Fusion
medium was replaced with a growth medium, the cells were further incubated at
40 °C for 2 h, and then the cells were fixed with a 1:1 mixture of methanol and
acetone and stained with Giemsa’s solution.
Preparation of E-protein mutants and neutralization assay. Recombinant
TBEV (Oshima 5–10 strain) was prepared from infectious cDNA clones, Oshima-
IC as reported previously54. To introduce mutations, cDNA fragments with the
mutations were synthesized by standard fusion-PCR and subcloned into Oshima-
IC in a stepwise manner. Infectious RNA was transcribed from Oshima-IC using
mMESSAGE mMACHINE SP6 (Thermo Fisher) and transfected into BHK-21 cells
using TransIT-mRNA (Mirus Bio LLC), as described previously54. Recombinant
viruses were recovered from cell culture supernatants.
To measure the ability of antibody 19/1786 to neutralize the TBEV, the mutant
viruses were incubated with serially diluted antibody and inoculated into BHK-21
cells. The cells were grown in minimal essential medium containing 1.5%
carboxymethyl cellulose and 2% FBS for 4 days. After 4 days of incubation, the cells
were fixed with 10% formalin and stained with 0.1% crystal violet. Plaques were
counted and expressed as plaque-forming units (PFU ml−1), and the reduction in
the number of plaques by the antibody was evaluated. The neutralization
experiments were done in triplicates. Neutralization curves were constructed from
the measured data and EC50 values with corresponding standard errors were
calculated from the fitted Hill dose-response curve. For statistical comparison of
the means of groups, an unpaired t-test was used and the corresponding p-values
are reported.
Preparation and sequencing of Fab 19/1786. Fab 19/1786 fragments were pre-
pared and purified with a Pierce™ Fab Preparation Kit (Thermo Scientific) from
mouse monoclonal IgG1 19/178639. The amino acid sequence of the variable
regions of the antibody was determined by mass-spectroscopy analysis and by
sequencing cDNA from hybridoma cells according to Wang et al55.
Cryo-EM sample preparation and data acquisition. To prepare the virus–Fab 19/
1786 complex, TBEV particles were incubated with the Fab 19/1786 for 2 h at 4 °C,
using equimolar amounts of the Fab fragments and E-proteins. To study the
mechanism of virus neutralization by Fab 19/1786, the pH of the sample was
adjusted to 5.8 with 100 mM MES pH 5.5 and the sample was incubated for 15 min
at 4 °C. Samples for cryo-EM were vitrified using an FEI Vitrobot Mark IV on
Quantifoil R2/1 grids with the following settings: 3.8 µl sample; wait time 10 s; blot
time 2 s; blot force −2.
The grids with vitrified virions were loaded into an FEI Titan Krios microscope
operating at 300 kV, equipped with an FEI Falcon II direct electron detector. The
microscope illumination and projection system was aligned before data acquisition,
and the astigmatism and coma-free alignments were corrected every 12 h during
the acquisition process. The micrographs were acquired using the automated
acquisition software EPU (FEI) at defoci varying between 1 and 3 μm at 75,000×
magnification, resulting in a pixel size of 1.063 Å. Six acquisition areas were defined
per foil-hole and autofocus was performed before the acquisition of each foil-hole.
Images were recorded as seven-frame movies, with a total exposure time of 0.5 s
and dose of 22 e−Å−2.
Data processing and volume reconstruction. The seven-frame movies were
aligned and summed using the program motioncor256. The contrast transfer
function (CTF) of the micrographs was estimated by gCTF57. Due to the high
heterogeneity of the sample, the particles were manually boxed using e2boxer from
the package EMAN258. Because of the large resulting box size, the particles were
down-sampled using XMIPP FFT binning59 to a box size of 512 × 512 pixels, which
resulted in a pixel size of 1.46 Å.
Particle images of native TBEV (19,111) and TBEV–Fab complex (12,098) were
subjected to several rounds of 2D and 3D classification performed using the
software package RELION60. An electron density map of Dengue virus 2 (EMDB:
EMD-5520)8 low-pass filtered to 60 Å was used as an initial model for 3D
classifications and refinements of TBEV. The classification steps resulted in the
selection of 11,882 particles of native TBEV and 5929 particles of the TBEV–Fab
complex, which were used for the final reconstruction according to the gold
standard using the 3Dautorefine procedure in RELION. The resulting maps were
masked and B-factor sharpened using the post-process procedure in RELION61.
Resolutions of the reconstructions were determined as points where FSC fell below
0.143. Local resolutions of the maps were determined using the post-process
procedure in RELION.
For the reconstruction of the TBEV–Fab complex at low pH, single non-
overlapping particles were boxed from the micrographs. Reference-free 2D
classification was used to remove damaged particles. The TBEV structure low-pass
filtered to 60 Å was used as an initial model. The particles were subjected to 3D
classification; however, this approach did not lead to a single class of uniform
particles, but instead in each iteration the particles redistributed randomly among
the three generated classes. Thus, all the particles that passed the 2D classification
were used for the reconstruction process, which did not lead to a high-resolution
map. We repeated the reconstruction with C1, C5, and icosahedral symmetries, as
well as with masks of different sizes in an attempt to remove the most pleiomorphic
parts of the particles from the orientation determination process. The best results
were achieved by masking out the region including the Fab fragments, and aligning
the particles only according to the features of the underlying TBEV particle. The
data set was homogenized by 3D classification that used the orientations of the
particles from the previous reconstruction. This approach partially eliminated
some of the variability in the region containing the Fab fragments. The final
reconstruction based on 3831 particle images was calculated using RELION.
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Sub-particle reconstruction to determine Fab occupancy. To quantify the
occupancy of Fab fragments at the two E-protein interaction sites, sub-particles of
Fab fragments were extracted from the particle images using the localized recon-
struction tools in RELION43. Orientations of the virus particles determined during
the 3D reconstruction were used for the extraction process. The sub-particles were
3D-classified using RELION, and the number of particles in classes representing
occupied and unoccupied sites were summed. Because the Fab fragments present at
the 3-fold axis of the particle were too close to each other to extract separately, they
were extracted as one sub-particle and a tight mask around each Fab fragment was
used during the 3D classification process.
Model building. Cryo-EM maps of native TBEV and the TBEV–Fab complex were
re-oriented so that the 222 subset of icosahedral symmetry axes was aligned with
the Cartesian coordinate axes. The maps were cropped, normalized, and set to
crystallographic P23 symmetry. This treatment of the maps resulted in five ico-
sahedral asymmetric units in one “crystallographic” asymmetric unit of the
P23 space group and enabled efficient refinement of the structures.
An initial model of the E-protein was generated based on the known crystal
structure of the ectodomain (PDB:1SVB)27 and the transmembrane domains of
Dengue virus type 2 and the Zika virus (PDB:5IRE,3J27)8,23 using the program
Modeller62. The model was rigid-body fitted to the electron density map of the
TBEV particle using the program Chimera63. Subsequently, the structure was
manually corrected using the program Coot64, followed by real-space refinement in
Phenix65 and reciprocal space refinement in Refmac566. The model of the M-
protein was built in the same manner. The complete icosahedral asymmetric unit
containing three E-proteins and three M-proteins was refined using the program
Refmac5 with imposed icosahedral symmetry constraints.
The initial homology model of the Fab 19/1786 was generated using the
program Modeller based on the PDB structures of multiple Fabs (PDB: 2H1P,
3FFD, 3LIZ, 5DO2, 5T6P, 4AEI, 5B4M, 1MEX). The resulting model was rigid-
body fitted to the measured electron density and refined together with the
interacting E-proteins using the real-space refinement procedure in Phenix65.
Analysis of the molecular models. The quality of the structures was assessed with
the MolProbity server67 and wwPDB validation service. Intermolecular interfaces
and interacting amino acids were identified using the programs PDBePISA and
UCSF Chimera63. Protein sequences were compared using the program Clustal
Omega, and the conservation of the amino acids was visualized using the program
Consurf68. Predictions of pKa were calculated using Rosetta-pKa36, according to
the method described for DENV E-protein by Chaudhury et al69. Electrostatic
surfaces were visualized in the program PyMOL using the APBS and PDB2PQR
plugins.
Data availability. Cryo-EM electron density maps of the native TBEV virion and
its complexes with Fab fragments at neutral and low pH have been deposited in the
Electron Microscopy Data Bank, https://www.ebi.ac.uk/pdbe/emdb/ (accession
numbers EMD-3752, EMD-3754, and EMD-3755), and the fitted coordinates have
been deposited in the Protein Data Bank, www.pdb.org (PDB ID codes 5O6A and
5O6V, respectively). The additional data that support the findings of this study are
available from the corresponding author upon request.
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